Search results
Results From The WOW.Com Content Network
lonza.com. Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development ...
Lonza Group Ag (LZAGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Actelion replaced by Lonza Group after Actelion's purchase by Johnson & Johnson. [20] In the same month, Sika AG replaced Syngenta after its purchase by ChemChina. [21] June 2018: Sika announced a 1:60 stock split. [22] Before this change, it was the SMI constituent with the highest price per share. April 2019
The stock of Lonza Group (OTCPK:LZAGY, 30-year Financials) is believed to be significantly overvalued, according to GuruFocus Value calculation.
Lonza's Biologics unit produces monoclonal antibodies and drug conjugates, and comprises approximately 45% of its annual sale Swiss pharma firm Lonza's profit falls less than feared, shares rise ...
Language links are at the top of the page across from the title.
For premium support please call: 800-290-4726 more ways to reach us
Basler Kantonalbank. BB Biotech. BELIMO Holding AG. Bell Food Group. Bellevue Group. Berner Kantonalbank. BKW Energie. Bobst (company) Bossard Group.